219 related articles for article (PubMed ID: 37401718)
21. [[CARDIORENAL SYNDROMES : DEFINITION AND CLASSIFICATION].
Moulin B
Rev Prat; 2016 Jun; 66(6):608-10. PubMed ID: 27538311
[TBL] [Abstract][Full Text] [Related]
22. Levels of Proinflammatory Cytokines, Oxidative Stress, and Tissue Damage Markers in Patients with Acute Heart Failure with and without Cardiorenal Syndrome Type 1.
Virzì GM; Breglia A; Brocca A; de Cal M; Bolin C; Vescovo G; Ronco C
Cardiorenal Med; 2018; 8(4):321-331. PubMed ID: 30205401
[TBL] [Abstract][Full Text] [Related]
23. Benefit of natriuresis and cardiac resynchronisation therapy in acute decompensated heart failure with cardiorenal syndrome and hypernatraemia.
Khojah AT; Katz E; Pace R; Rajendram R
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35787494
[TBL] [Abstract][Full Text] [Related]
24. Hemodialysis treatment of cardiorenal syndrome.
Leskovar B; Furlan T; Poznič S; Potisek M; Adamlje A
Clin Nephrol; 2017 Supplement 1; 88(13):57-60. PubMed ID: 28655387
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcomes and 30-day readmissions for heart failure with reduced ejection fraction with cardiorenal syndrome: A National Cohort Study.
Shanah L; Mir T; Uddin MM; Hussain T; Parajuli T; Bhat Z
Int J Cardiol; 2023 Jan; 370():244-249. PubMed ID: 36328112
[TBL] [Abstract][Full Text] [Related]
26. Left Ventricular Assist Device and the Kidney: Getting to the Heart of the Matter.
Kamboj M; Kazory A
Blood Purif; 2019; 48(4):289-298. PubMed ID: 31454818
[TBL] [Abstract][Full Text] [Related]
27. [Cardiorenal anemia syndrome (review)].
Minasyan A
Georgian Med News; 2012 Dec; (213):17-21. PubMed ID: 23293227
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection Fraction.
Rieger AC; Tompkins BA; Natsumeda M; Florea V; Banerjee MN; Rodriguez J; Rosado M; Porras V; Valasaki K; Takeuchi LM; Collon K; Desai S; Bellio MA; Khan A; Kashikar ND; Landin AM; Hardin DV; Rodriguez DA; Balkan W; Hare JM; Schulman IH
Stem Cells Transl Med; 2022 Mar; 11(1):59-72. PubMed ID: 35641169
[TBL] [Abstract][Full Text] [Related]
29. A Clinical Approach to the Acute Cardiorenal Syndrome.
Jentzer JC; Chawla LS
Crit Care Clin; 2015 Oct; 31(4):685-703. PubMed ID: 26410138
[TBL] [Abstract][Full Text] [Related]
30. [Cardiorenal syndromes].
Késöi I; Sági B; Vas T; Pintér T; Kovács T; Wittmann I; Nagy J
Orv Hetil; 2011 Sep; 152(38):1520-7. PubMed ID: 21896443
[TBL] [Abstract][Full Text] [Related]
31. Cardiorenal syndrome - a new classification and current evidence on its management.
Ahmed MS; Wong CF; Pai P
Clin Nephrol; 2010 Oct; 74(4):245-57. PubMed ID: 20875376
[TBL] [Abstract][Full Text] [Related]
32. Heart-Kidney Interactions in Cardiorenal Syndrome Type 1.
Palazzuoli A; Ruocco G
Adv Chronic Kidney Dis; 2018 Sep; 25(5):408-417. PubMed ID: 30309458
[TBL] [Abstract][Full Text] [Related]
33. Peritoneal Dialysis for Chronic Congestive Heart Failure.
François K; Ronco C; Bargman JM
Blood Purif; 2015; 40(1):45-52. PubMed ID: 26111872
[TBL] [Abstract][Full Text] [Related]
34. [Clinical practice guideline for the diagnosis and treatment of cardiorenal syndrome (2023 Edition)].
Cardiorenal Syndrome Guidelines Working Group of Chinese Nephrologist Association of Chinese Medical Doctor Association
Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(46):3705-3759. PubMed ID: 38092552
[TBL] [Abstract][Full Text] [Related]
35. Lipopolysaccharide in systemic circulation induces activation of inflammatory response and oxidative stress in cardiorenal syndrome type 1.
Virzì GM; Breglia A; Castellani C; Ankawi G; Bolin C; de Cal M; Cianci V; Angelini A; Vescovo G; Ronco C
J Nephrol; 2019 Oct; 32(5):803-810. PubMed ID: 31006081
[TBL] [Abstract][Full Text] [Related]
36. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association.
Rangaswami J; Bhalla V; Blair JEA; Chang TI; Costa S; Lentine KL; Lerma EV; Mezue K; Molitch M; Mullens W; Ronco C; Tang WHW; McCullough PA;
Circulation; 2019 Apr; 139(16):e840-e878. PubMed ID: 30852913
[TBL] [Abstract][Full Text] [Related]
37. Heart-kidney interactions: mechanistic insights from animal models.
Liu S
Am J Physiol Renal Physiol; 2019 May; 316(5):F974-F985. PubMed ID: 30838876
[TBL] [Abstract][Full Text] [Related]
38. Cardiorenal syndrome in critical care: the acute cardiorenal and renocardiac syndromes.
Cruz DN
Adv Chronic Kidney Dis; 2013 Jan; 20(1):56-66. PubMed ID: 23265597
[TBL] [Abstract][Full Text] [Related]
39. Effect of ultrafiltration versus intravenous furosemide for decompensated heart failure in cardiorenal syndrome: a systematic review with meta-analysis of randomized controlled trials.
Chen HY; Chou KJ; Fang HC; Chen CL; Hsu CY; Huang WC; Huang CW; Huang CK; Lee PT
Nephron; 2015; 129(3):189-96. PubMed ID: 25765606
[TBL] [Abstract][Full Text] [Related]
40. The acute kidney injury to chronic kidney disease transition in a mouse model of acute cardiorenal syndrome emphasizes the role of inflammation.
Matsushita K; Saritas T; Eiwaz MB; McClellan N; Coe I; Zhu W; Ferdaus MZ; Sakai LY; McCormick JA; Hutchens MP
Kidney Int; 2020 Jan; 97(1):95-105. PubMed ID: 31623859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]